Federal Register / Vol. 88, No. 187 / Thursday, September 28, 2023 / Notices 66863 

Place: National Institutes of Health, 

Rockledge I, 6705 Rockledge Drive, Bethesda, 

MD 20892 (Virtual Meeting). 

Contact Person: Manoj K. Valiyaveettil, 

Ph.D., Scientific Review Officer, Blood & 

Vascular Branch, Office Scientific Review, 

Division of Extramural Research Activities 

(DERA), National Institute of Health, 

National Heart, Lung, and Blood Institute, 

Bethesda, MD 20817, (301) 402–1616, 

manoj.valiyaveettil@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.233, National Center for 

Sleep Disorders Research; 93.837, Heart and 

Vascular Diseases Research; 93.838, Lung 

Diseases Research; 93.839, Blood Diseases 

and Resources Research, National Institutes 

of Health, HHS) 

Dated: September 22, 2023. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2023–21144 Filed 9–27–23; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Human Genome Research 

Institute; Notice of Closed Meeting 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Inherited 

Disease Research Access Committee. 

Date: November 3, 2023. 

Time: 11:30 a.m. to 12:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

National Human Genome Research Institute, 

6700B Rockledge Drive, Room 3172, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Barbara J. Thomas, Ph.D., 

Scientific Review Officer, Scientific Review 

Branch, National Institutes of Health, 

National Human Genome Research Institute, 

6700B Rockledge Drive, Room 3172, 

Bethesda, MD 20892, (301) 402–8837, 

barbara.thomas@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.172, Human Genome 

Research, National Institutes of Health, HHS) 

Dated: September 22, 2023. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2023–21148 Filed 9–27–23; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Aging; Notice of 

Closed Meeting 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Aging Special Emphasis Panel; MultiComponent Application. 

Date: October 25, 2023. 

Time: 1:00 p.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute on Aging, 

Gateway Building, 7201 Wisconsin Avenue, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Dario Dieguez, Ph.D., 

Scientific Review Officer, National Institute 

on Aging, Scientific Review Branch, Gateway 

Building, 7201 Wisconsin Avenue (2W218), 

Bethesda, MD 20892, (301) 827–3101, 

dario.dieguez@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.866, Aging Research, 

National Institutes of Health, HHS) 

Dated: September 22, 2023. 

Miguelina Perez, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2023–21155 Filed 9–27–23; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Heart, Lung, and Blood 

Institute; Notice of Meeting 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of a 

meeting of the Sickle Cell Disease 

Advisory Committee. 

The meeting will be held as a virtual 

meeting and will be open to the public 

as indicated below. Individuals who 

plan to view the virtual meeting and 

need special assistance or other 

reasonable accommodations to view the 

meeting, should notify the Contact 

Person listed below in advance of the 

meeting. The meeting can be accessed 

from the NIH Videocast at the following 

link: https://videocast.nih.gov/. 

Name of Committee: Sickle Cell Disease 

Advisory Committee. 

Date: January 29, 2024. 

Time: 10:00 a.m. to 3:00 p.m. 

Agenda: NHLBI Sickle Cell Disease 

Program Updates. 

Place: National Institutes of Health, 

Rockledge Centre I, 6705 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Telephone Access: +1 669 254 5252 

(Meeting ID 160 763 2658). Virtual Access: 

https://nih.zoomgov.com/j/1607632658 

(Meeting ID: 160 763 2658). 

Contact Person: Julie A. Panepinto, MD, 

MSPH, SCDAC Executive Secretary, Director, 

Division of Blood Diseases and Resources, 

National Institutes of Health, National Heart, 

Lung, and Blood Institute, 6701 Rockledge 

Drive, Suite 9166, Bethesda, MD 20892, 301– 

435–0080, NHLBIDBDRGrantResource@

nhlbi.nih.gov. 

Any member of the public interested in 

presenting oral comments to the committee 

may notify the Contact Person listed on this 

notice at least 10 days in advance of the 

meeting. Interested individuals and 

representatives of organizations may submit 

a letter of intent, a brief description of the 

organization represented, and a short 

description of the oral presentation. Only one 

representative of an organization may be 

allowed to present oral comments and if 

accepted by the committee, presentations 

may be limited to five minutes. Both printed 

and electronic copies are requested for the 

record. In addition, any interested person 

may file written comments with the 

committee by forwarding their statement to 

the Contact Person listed on this notice. The 

statement should include the name, address, 

telephone number and when applicable, the 

business or professional affiliation of the 

interested person. 

Information is also available on the 

Institute’s/Center’s home page: https://

www.nhlbi.nih.gov/advisory-and-peerreview-committees/nhlbi-sickle-cell-diseaseadvisory-committee, where an agenda and 

any additional information for the meeting 

will be posted when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.233, National Center for 

Sleep Disorders Research; 93.837, Heart and 

Vascular Diseases Research; 93.838, Lung 

Diseases Research; 93.839, Blood Diseases 

and Resources Research, National Institutes 

of Health, HHS) 


ddrumheller on DSK120RN23PROD with NOTICES1